Courtney W. Houchen, M.D. is the George Lynn Cross Research Professor, Regents Professor, Eason Chair of Oncology, and Chief of the Section of Digestive Diseases & Nutrition in the Department of Medicine at the University of Oklahoma Health Sciences Center. He has over 25 years of experience in the biology of normal and cancer epithelial stem cells. His research lab is actively pursuing therapeutic interventions that functionally inactivate or delete cancer cells that exhibit properties that promote metastasis. He is the founder and currently the Chief Medical Adviser for COARE. He has authored over 100 peer-reviewed manuscripts, abstracts, and book chapters and has active and past funding from the NIH, NCI, VA, DOD, and private foundations.


Edwin Bannerman-Menson is the CEO of COARE and a co-founder. He has over 25 years of experience in corporate business development, and for the last 10 years has been responsible for research and development, fundraising applied research coordination and commercialization strategy development at COARE. He maintains constant communication with the federal government, contract research organizations, intellectual property attorneys and scientific research collaborators in order to fulfill COARE’s business objectives. He is responsible for obtaining several million in non-dilutive NIH funding that has enabled COARE to develop its novel first-in-class platform technologies.